Biological Information
Background Information:
Adenosine Na⁺-independent nucleoside transporters (Equilibrative nucleoside transporters, ENTs) are integral membrane proteins that mediate the bidirectional, passive transport of nucleosides and nucleobases across cellular membranes, driven by concentration gradients. ENTs play essential roles in nucleotide metabolism by enabling the recycling of purine and pyrimidine nucleosides for DNA synthesis, energy metabolism, and cellular signaling. In humans, four ENT isoforms (ENT1–ENT4) have been identified, each with distinct substrate specificities, tissue distribution patterns, and physiological functions. ENT1 and ENT2 are the most well-characterized, widely expressed, and primarily involved in transporting naturally occurring nucleosides and nucleobases. Beyond their physiological roles, ENTs are pharmacologically important for mediating the uptake of nucleoside-derived drugs, including anticancer and antiviral agents.
Family:
Transporter
Sub Family:
SLC29 / Nucleoside
Class:
SLC
Organism:
Human
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Binding
Detection Method:
Radiometry
Measured Response:
Scintillation
Testing Information
Procedure Summary:
This assay measures binding of [³H]Nitrobenzylthioinosine to sites associated with the transporter of adenosine. Human adenosine transporter membranes are prepared in Tris-HCl buffer pH 7.4. A 24 µg‡ aliquot of membrane is incubated with 0.5 nM [³H]Nitrobenzylthioinosine for 60 minutes at 25℃. Non-specific binding is estimated in the presence of 5 µM nitrobenzylthioinosine. Membranes are filtered and washed, the filters are then counted to determine [³H]Nitrobenzylthioinosine specifically bound. Compounds are screened at 10 µM.
Note: ‡Membrane protein may change from lot to lot, the concentration used will be adjusted if necessary.
Ligand:
[³H] Nitrobenzylthioinosine
Ligand Kd (nM):
0.37
Ligand Concentration:
0.5 nM
Non Specific:
5 µM Nitrobenzylthioinosine
Incubation:
60 min at 25°C
Control Inhibitor:
NBTI
Criteria For Significance:
≥ 50% of max stimulation or inhibition
Test Concentration / Dose:
Suggested concentration for initial testing is 10 uM
Test Sample Requirements:
Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).
Minimum Order Quantity:
2
Turnaround Time
Standard:
15 Business Days
Reference Compound Data
Additional Information
Brand:
LeadHunter
Testing Location:
Taiwan - Taipei